Older diabetics who took GlaxoSmithKline's Avandia to control their blood sugar had a higher risk of death and heart failure while on the drug than those who took Takeda Pharmaceutical's Actos, a drug in the same class, U.S. researchers said on Monday.
They said the head-to-head comparison confirms prior analyses finding Avandia carries greater risks than Actos, particularly in older diabetics. . . .
Reuters - November 24, 2008
http://www.reuters.com/article/healthNews/idUSTRE4AO0Q620081125?feedType=RSS&feedName=healthNews
